BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Diagnosis
43 results:

  • 1. Risk of secondary primary malignancies in survivors of upper tract urothelial carcinoma: A nationwide population-based analysis.
    Wu KY; Cheong IS; Lai JN; Hu CY; Hung KC; Chen YT; Chiu LT; Tsai HT; Jou YC; Tzai TS; Tsai YS
    Cancer Epidemiol; 2024 Apr; 89():102536. PubMed ID: 38281454
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Diagnostic accuracy of magnifying chromoendoscopy in the assessment of tumor invasion depth in early colorectal cancer: a systematic review and meta-analysis.
    Huang Y; Yang Z; Yao Y; Liu G; Chen R
    Tech Coloproctol; 2023 Dec; 27(12):1155-1167. PubMed ID: 37474693
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CDCA8 Facilitates Tumor Proliferation and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
    Cui Y; Jiang N
    Appl Biochem Biotechnol; 2024 Mar; 196(3):1481-1492. PubMed ID: 37428386
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
    Lapitz A; Azkargorta M; Milkiewicz P; Olaizola P; Zhuravleva E; Grimsrud MM; Schramm C; Arbelaiz A; O'Rourke CJ; La Casta A; Milkiewicz M; Pastor T; Vesterhus M; Jimenez-Agüero R; Dill MT; Lamarca A; Valle JW; Macias RIR; Izquierdo-Sanchez L; Pérez Castaño Y; Caballero-Camino FJ; Riaño I; Krawczyk M; Ibarra C; Bustamante J; Nova-Camacho LM; Falcon-Perez JM; Elortza F; Perugorria MJ; Andersen JB; Bujanda L; Karlsen TH; Folseraas T; Rodrigues PM; Banales JM
    J Hepatol; 2023 Jul; 79(1):93-108. PubMed ID: 36868481
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Construction of a combined random forest and artificial neural network diagnosis model to screening potential biomarker for hepatoblastoma.
    Liu S; Zheng Q; Zhang R; Li T; Zhan J
    Pediatr Surg Int; 2022 Dec; 38(12):2023-2034. PubMed ID: 36271952
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Simplified LI-RADS for Hepatocellular Carcinoma diagnosis at Gadoxetic Acid-enhanced MRI.
    Kwag M; Choi SH; Choi SJ; Byun JH; Won HJ; Shin YM
    Radiology; 2022 Dec; 305(3):614-622. PubMed ID: 35972362
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders.
    Mbaga DS; Kenmoe S; Kengne-Ndé C; Ebogo-Belobo JT; Mahamat G; Foe-Essomba JR; Amougou-Atsama M; Tchatchouang S; Nyebe I; Feudjio AF; Kame-Ngasse GI; Magoudjou-Pekam JN; Fokou LKM; Meta-Djomsi D; Maïdadi-Foudi M; Touangnou-Chamda SA; Daha-Tchoffo AG; Selly-Ngaloumo AA; Nayang-Mundo RA; Yéngué JF; Taya-Fokou JB; Kenfack-Momo R; Atembeh Noura E; Demeni Emoh CP; Tazokong HR; Bowo-Ngandji A; Sake CS; Atenguena Okobalemba E; Njiki Bikoi J; Njouom R; Riwom Essama SH
    PLoS One; 2022; 17(1):e0262903. PubMed ID: 35061846
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Platelets' RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules.
    Waqar W; Asghar S; Manzoor S
    PLoS One; 2021; 16(9):e0256739. PubMed ID: 34469466
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diagnostic Performance of 2018 KLCA-NCC Practice Guideline for Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced MRI in Patients with Chronic Hepatitis B or Cirrhosis: Comparison with LI-RADS Version 2018.
    Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH
    Korean J Radiol; 2021 Jul; 22(7):1066-1076. PubMed ID: 33739633
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. An evaluation of
    Sangaré L; Delli-Zotti K; Florea A; Rehn M; Benson AB; Lowe KA
    Future Oncol; 2021 May; 17(13):1653-1663. PubMed ID: 33629919
    [No Abstract]    [Full Text] [Related]  

  • 11. Improved survival following transarterial radioembolization of infiltrative-appearance hepatocellular carcinoma.
    Nisiewicz MJ; Kapoor H; Fowler KJ; Furlan A; Dugan AJ; Owen JW
    Abdom Radiol (NY); 2021 May; 46(5):1958-1966. PubMed ID: 33385248
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. LI-RADS Version 2017 versus Version 2018: diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI.
    Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH
    Radiology; 2019 Sep; 292(3):655-663. PubMed ID: 31310175
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinicopathologic Features of Colorectal Polyps in Shahid Beheshti University of Medical Sciences (SBMU).
    Ahadi M; Kazemi Nejad B; Kishani Farahani Z; Mollasharifi T; Jamali E; Mohaghegh Shalmani H; Dehgan A; Saberi Afsharian M; Sadeghi A; Movafagh A; Boran R; Rakhshan A; Moradi A; Heidari MH; Moradi A
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1773-1780. PubMed ID: 31244299
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
    Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
    Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long-term follow-up study of 1317 patients.
    Nilsson E; Anderson H; Sargenti K; Lindgren S; Prytz H
    Aliment Pharmacol Ther; 2019 Jun; 49(11):1421-1430. PubMed ID: 30957910
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.
    Althoff KN; Gebo KA; Moore RD; Boyd CM; Justice AC; Wong C; Lucas GM; Klein MB; Kitahata MM; Crane H; Silverberg MJ; Gill MJ; Mathews WC; Dubrow R; Horberg MA; Rabkin CS; Klein DB; Lo Re V; Sterling TR; Desir FA; Lichtenstein K; Willig J; Rachlis AR; Kirk GD; Anastos K; Palella FJ; Thorne JE; Eron J; Jacobson LP; Napravnik S; Achenbach C; Mayor AM; Patel P; Buchacz K; Jing Y; Gange SJ;
    Lancet HIV; 2019 Feb; 6(2):e93-e104. PubMed ID: 30683625
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Reduced Incidence and Better liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis.
    Adejumo AC; Adegbala OM; Adejumo KL; Bukong TN
    Can J Gastroenterol Hepatol; 2018; 2018():9430953. PubMed ID: 30345261
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features?
    Joo I; Lee JM; Lee DH; Jeon JH; Han JK
    Eur Radiol; 2019 Apr; 29(4):1724-1732. PubMed ID: 30255250
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis.
    Li J; Li Z; Jiang P; Peng M; Zhang X; Chen K; Liu H; Bi H; Liu X; Li X
    J Exp Clin Cancer Res; 2018 Jul; 37(1):177. PubMed ID: 30064461
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinoma.
    Pinato DJ; Sharma R; Citti C; Platt H; Ventura-Cots M; Allara E; Chen TY; Dalla Pria A; Jain M; Mínguez B; Kikuchi L; Kaufman West E; Merli M; Kaplan DE; Hasson H; Marks K; Nelson M; Núñez M; Aytaman A; Bower M; Bräu N;
    Aliment Pharmacol Ther; 2018 Jan; 47(1):95-103. PubMed ID: 29034998
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.